Types of Gastric Carcinomas
Abstract
:1. Present Classifications
2. Cells in the Oxyntic Mucosa with the Ability to Divide and Their Growth Regulation
3. Cells in the Antral Mucosa with the Ability to Divide
4. Etiology of Gastric Carcinomas
5. Pathogenesis of Gastric Carcinomas
6. Intestinal Type of Gastric Carcinoma
7. Diffuse Type of Gastric Carcinoma
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Kilgore, S.P.; Ormsby, A.H.; Gramlich, T.L.; Rice, T.W.; Richter, J.E.; Falk, G.W.; Goldblum, J.R. The gastric cardia: Fact or fiction? Am. J. Gastroenterol. 2000, 95, 921–924. [Google Scholar] [CrossRef] [PubMed]
- Choi, E.; Roland, J.T.; Barlow, B.J.; O′Neal, R.; Rich, A.E.; Nam, K.T.; Shi, C.; Goldenring, J.R. Cell lineage distribution atlas of the human stomach reveals heterogeneous gland populations in the gastric antrum. Gut 2014, 63, 1711–1720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tielemans, Y.; Willems, G.; Sundler, F.; Håkanson, R. Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990, 45, 138–146. [Google Scholar] [CrossRef] [PubMed]
- Tsolakis, A.V.; Portela-Gomes, G.M.; Stridsberg, M.; Grimelius, L.; Sundin, A.; Eriksson, B.K.; Oberg, K.E.; Janson, E.T. Malignant gastric ghrelinoma with hyperghrelinemia. J. Clin. Endocrinol. MeTable 2004, 89, 3739–3744. [Google Scholar] [CrossRef] [PubMed]
- Borrmann, R. Geschwülste des Magens und Duodenums. In Handbuch des Speziellen Pathologischen Anatomie und Histologie; Henke, F., Lubarsch, O., Eds.; Springer: Berlin, Germany, 1926. [Google Scholar]
- Oota, K.; Sobin, L.H. Histological typing of gastric and oesophageal tumours. In International Histological Classification of Tumours; WHO: Geneva, Switzerland, 1977. [Google Scholar]
- Laurén, P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. APMIS 6: 209–222. Acta Pathol. Microbiol. Scand. 1965, 6, 31–49. [Google Scholar] [CrossRef]
- Ming, S.C. Gastric carcinoma. A pathobiological classification. Cancer 1977, 39, 2475–2485. [Google Scholar] [CrossRef]
- Fuchs, C.S.; Mayer, R.J. Gastric carcinoma. N. Engl. J. Med. 1995, 333, 32–41. [Google Scholar] [CrossRef] [PubMed]
- Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014, 513, 202–209. [CrossRef] [PubMed] [Green Version]
- Waldum, H.L.; Sagatun, L.; Mjones, P. Gastrin and Gastric Cancer. Front. Endocrinol. 2017, 8, 1. [Google Scholar] [CrossRef]
- Andrew, A.; Kramer, B.; Rawdon, B.B. The origin of gut and pancreatic neuroendocrine (APUD) cells--the last word? J. Pathol. 1998, 186, 117–118. [Google Scholar] [CrossRef]
- Nam, K.T.; Lee, H.J.; Sousa, J.F.; Weis, V.G.; O’Neal, R.L.; Finke, P.E.; Romero-Gallo, J.; Shi, G.; Mills, J.C.; Peek, R.M. Jr.; et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010, 139, 2028–2037. [Google Scholar] [CrossRef] [PubMed]
- Hayakawa, Y.; Ariyama, H.; Stancikova, J.; Sakitani, K.; Asfaha, S.; Renz, B.W.; Dubeykovskaya, Z.A.; Shibata, W.; Wang, H.; Westphalen, C.B.; et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell 2015, 28, 800–814. [Google Scholar] [CrossRef] [PubMed]
- Larsson, L.I. Developmental biology of gastrin and somatostatin cells in the antropyloric mucosa of the stomach. Microsc. Res. Tech. 2000, 48, 272–281. [Google Scholar] [CrossRef]
- Morson, B.C. Intestinal metaplasia of the gastric mucosa. Br. J. Cancer 1955, 9, 365–376. [Google Scholar] [CrossRef] [PubMed]
- Marshall, B.J.; Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1, 1311–1315. [Google Scholar] [CrossRef]
- Parsonnet, J.; Friedman, G.D.; Vandersteen, D.P.; Chang, Y.; Vogelman, J.H.; Orentreich, N.; Sibley, R.K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991, 325, 1127–1131. [Google Scholar] [CrossRef] [PubMed]
- Kato, M.; Asaka, M.; Shimizu, Y.; Nobuta, A.; Takeda, H.; Sugiyama, T. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment. Pharmacol. Ther. 2004, 20, 85–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hansson, L.E.; Nyren, O.; Hsing, A.W.; Bergstrom, R.; Josefsson, S.; Chow, W.H.; Fraumeni Jr, J.F.; Adami, H.O. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 1996, 335, 242–249. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Hauso, O.; Sordal, O.F.; Fossmark, R. Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Dig. Dis. Sci. 2015, 60, 1522–1527. [Google Scholar] [CrossRef] [PubMed]
- Testoni, P.A.; Masci, E.; Marchi, R.; Guslandi, M.; Ronchi, G.; Tittobello, A. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk. J. Clin. Gastroenterol. 1987, 9, 298–302. [Google Scholar] [CrossRef] [PubMed]
- Uemura, N.; Okamoto, S.; Yamamoto, S.; Matsumura, N.; Yamaguchi, S.; Yamakido, M.; Taniyama, K.; Sasaki, N.; Schlemper, R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345, 784–789. [Google Scholar] [CrossRef] [PubMed]
- Martinsen, T.C.; Bergh, K.; Waldum, H.L. Gastric juice: A barrier against infectious diseases. Basic Clin Pharmacol. Toxicol. 2005, 96, 94–102. [Google Scholar] [CrossRef] [PubMed]
- Hansson, L.R.; Engstrand, L.; Nyren, O.; Lindgren, A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995, 109, 885–888. [Google Scholar] [CrossRef]
- Zamcheck, N.; Grable, E.; Ley, A.; Normal, L. Occurrence of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N. Engl. J. Med. 1955, 252, 1103–1110. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Sandvik, A.K.; Brenna, E.; Petersen, H. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut 1991, 32, 698–701. [Google Scholar] [CrossRef] [PubMed]
- Sandvik, A.K.; Waldum, H.L.; Kleveland, P.M.; Schulze Sognen, B. Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach. Scand. J. Gastroenterol. 1987, 22, 803–808. [Google Scholar] [CrossRef] [PubMed]
- Brenna, E.; Waldum, H.L. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: Establishment of a dose response relationship. Gut 1992, 33, 1303–1306. [Google Scholar] [CrossRef] [PubMed]
- Havu, N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986, 35, 42–55. [Google Scholar] [CrossRef] [PubMed]
- Poynter, D.; Selway, S.A.; Papworth, S.A.; Riches, S.R. Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. Gut 1986, 27, 1338–1346. [Google Scholar] [CrossRef] [PubMed]
- Lamberts, R.; Creutzfeldt, W.; Stockmann, F.; Jacubaschke, U.; Maas, S.; Brunner, G. Long-term omeprazole treatment in man: Effects on gastric endocrine cell populations. Digestion 1988, 39, 126–135. [Google Scholar] [CrossRef] [PubMed]
- Borch, K.; Renvall, H.; Liedberg, G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985, 88, 638–648. [Google Scholar] [CrossRef]
- Poynter, D. Long-term effects of reduced gastric acidity in laboratory animals. Digestion 1985, 31, 174. [Google Scholar]
- Cheung, K.S.; Chan, E.W.; Wong, A.Y.S.; Chen, L.; Wong, I.C.K.; Leung, W.K. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: A population-based study. Gut 2018, 67, 28–35. [Google Scholar] [CrossRef] [PubMed]
- Brusselaers, N.; Wahlin, K.; Engstrand, L.; Lagergren, J. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: A nationwide population-based cohort study in Sweden. BMJ Open 2017, 7, e017739. [Google Scholar] [CrossRef] [PubMed]
- Jianu, C.S.; Fossmark, R.; Viset, T.; Qvigstad, G.; Sordal, O.; Marvik, R.; Waldum, H.L. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment. Pharmacol. Ther. 2012, 36, 644–649. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Calvete, O.; Reyes, J.; Zuniga, S.; Paumard-Hernandez, B.; Fernandez, V.; Bujanda, L.; Rodriguez-Pinilla, M.S.; Palacios, J.; Heine-Suner, D.; Banka, S.; et al. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour. Hum. Mol. Genet. 2015, 24, 2914–2922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fossmark, R.; Calvete, O.; Mjones, P.; Benitez, J.; Waldum, H.L. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H K ATPase alpha subunit. APMIS 2016, 124, 561–566. [Google Scholar] [CrossRef] [PubMed]
- Bakke, I.; Qvigstad, G.; Sandvik, A.K.; Waldum, H.L. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand. J. Gastroenterol. 2001, 36, 1128–1133. [Google Scholar] [CrossRef] [PubMed]
- Zollinger, R.M.; Ellison, E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. 1955, 142, 709–723. [Google Scholar] [CrossRef] [PubMed]
- Larsson, H.; Carlsson, E.; Mattsson, H.; Lundell, L.; Sundler, F.; Sundell, G.; Wallmark, B.; Watanabe, T.; Håkanson, R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986, 90, 391–399. [Google Scholar] [CrossRef]
- Kazumori, H.; Ishihara, S.; Kawashima, K.; Fukuda, R.; Chiba, T.; Kinoshita, Y. Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS Lett. 2001, 489, 208–214. [Google Scholar] [CrossRef] [Green Version]
- Fukui, H.; Kinoshita, Y.; Maekawa, T.; Okada, A.; Waki, S.; Hassan, S.; Okamoto, H.; Chiba, T. Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 1998, 115, 1483–1493. [Google Scholar] [CrossRef]
- Brenna, E.; Waldum, H.L. Studies of isolated parietal and enterochromaffin-like cells from the rat. Scand. J. Gastroenterol. 1991, 26, 1295–1306. [Google Scholar] [CrossRef] [PubMed]
- Bakke, I.; Qvigstad, G.; Brenna, E.; Sandvik, A.K.; Waldum, H.L. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: A study by elutriation centrifugation. Acta Physiol. Scand. 2000, 169, 29–37. [Google Scholar] [CrossRef] [PubMed]
- Friis-Hansen, L.; Wierup, N.; Rehfeld, J.F.; Sundler, F. Antral G-cell in gastrin and gastrin-cholecystokinin knockout animals. Cell Tissue Res. 2005, 321, 141–146. [Google Scholar] [CrossRef] [PubMed]
- Shinozaki-Ushiku, A.; Kunita, A.; Fukayama, M. Update on Epstein-Barr virus and gastric cancer (review). Int. J. Oncol. 2015, 46, 1421–1434. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Hauso, O.; Fossmark, R. The regulation of gastric acid secretion—clinical perspectives. Acta Physiol. (Oxf.) 2014, 210, 239–256. [Google Scholar] [CrossRef] [PubMed]
- Barrett, P.; Hobbs, R.C.; Coates, P.J.; Risdon, R.A.; Wright, N.A.; Hall, P.A. Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem. J. 1995, 27, 482–486. [Google Scholar] [CrossRef] [PubMed]
- Qvigstad, G.; Sandvik, A.K.; Brenna, E.; Aase, S.; Waldum, H.L. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem. J. 2000, 32, 551–556. [Google Scholar] [CrossRef] [PubMed]
- Qvigstad, G.; Qvigstad, T.; Westre, B.; Sandvik, A.K.; Brenna, E.; Waldum, H.L. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS 2002, 110, 132–139. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Aase, S.; Kvetnoi, I.; Brenna, E.; Sandvik, A.K.; Syversen, U.; Johnsen, G.; Vatten, L.; Polak, J.M. Neuroendocrine differentiation in human gastric carcinoma. Cancer 1998, 83, 435–444. [Google Scholar] [CrossRef] [Green Version]
- Bakkelund, K.; Fossmark, R.; Nordrum, I.; Waldum, H. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J. Histochem. Cytochem. 2006, 54, 615–621. [Google Scholar] [CrossRef] [PubMed]
- Sordal, O.; Qvigstad, G.; Nordrum, I.S.; Sandvik, A.K.; Gustafsson, B.I.; Waldum, H. The PAS positive material in gastric cancer cells of signet ring type is not mucin. Exp. Mol. Pathol. 2014, 96, 274–278. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Sordal, O.F. Classification of Epithelial Malignant Tumors-the Differentiation Between Adenocarcinomas and Neuroendocrine Carcinomas: Why Rely on Nonspecific Histochemistry and Dismiss Specific Methods Like Immunohistochemistry and In Situ Hybridization? Appl Immunohistochem Mol. Morphol. 2016, 24, 309–312. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Q.; Lu, X.; Gan, L.; Chen, S.; Zhou, T.; Wang, L.; Si, J. Role of REG Ialpha in gastric carcinogenesis: Gastrin-associated proliferative and anti-apoptotic activities. Mol. Med. Rep. 2010, 3, 999–1005. [Google Scholar] [PubMed]
- El-Nujumi, A.; Williams, C.; Ardill, J.E.; Oien, K.; McColl, K.E. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment. Gut 1998, 42, 159–165. [Google Scholar] [CrossRef] [PubMed]
- Mjones, P.; Nordrum, I.S.; Sordal, O.; Sagatun, L.; Fossmark, R.; Sandvik, A.; Waldum, H.L. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells. Horm. Cancer 2018, 9, 40–54. [Google Scholar]
- Sei, Y.; Feng, J.; Samsel, L.; White, A.; Zhao, X.; Yun, S.; Citrin, D.; McCoy, J.P.; Sundaresan, S.; Hayes, M.M.; et al. Mature enteroendocrine cells contribute to basal and pathological stem cell dynamics in the small intestine. Am. J. Physiol. Gastrointest Liver Physiol. 2018, 315, 495–510. [Google Scholar] [CrossRef] [PubMed]
- Goetze, J.P.; Eiland, S.; Svendsen, L.B.; Vainer, B.; Hannibal, J.; Rehfeld, J.F. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas. Scand. J. Gastroenterol. 2013, 48, 688–695. [Google Scholar] [CrossRef] [PubMed]
- Hayakawa, Y.; Jin, G.; Wang, H.; Chen, X.; Westphalen, C.B.; Asfaha, S.; Renz, B.W.; Ariyama, H.; Dubeykovskaya, Z.A.; Takemoto, Y.; et al. CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut 2015, 64, 544–553. [Google Scholar] [CrossRef] [PubMed]
- Guilford, P.; Hopkins, J.; Harraway, J.; McLeod, M.; McLeod, N.; Harawira, P.; Taite, H.; Scoular, R.; Miller, A.; Reeve, A.E. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392, 402–405. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L.; Ringnes, E.; Nordbo, H.; Sordal, O.; Nordrum, I.S.; Hauso, O. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin. Scand. J. Gastroenterol. 2014, 49, 974–978. [Google Scholar] [CrossRef] [PubMed]
- Demitrack, E.S.; Samuelson, L.C. Notch as a Driver of Gastric Epithelial Cell Proliferation. Cell. Mol. Gastroenterol. Hepatol. 2017, 3, 323–330. [Google Scholar] [CrossRef] [PubMed]
- Parsonnet, J.; Vandersteen, D.; Goates, J.; Sibley, R.K.; Pritikin, J.; Chang, Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J. Natl. Cancer Inst. 1991, 83, 640–643. [Google Scholar] [CrossRef] [PubMed]
- Pittayanon, R.; Rerknimitr, R.; Klaikaew, N.; Sanpavat, A.; Chaithongrat, S.; Mahachai, V.; Kullavanijaya, P.; Barkun, A. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up. Aliment. Pharmacol. Ther. 2017, 46, 40–45. [Google Scholar] [CrossRef] [PubMed]
- Henson, D.E.; Dittus, C.; Younes, M.; Nguyen, H.; Albores-Saavedra, J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: Increase in the signet ring cell type. Arch. Pathol. Lab. Med. 2004, 128, 765–770. [Google Scholar] [PubMed]
- Hansen, S.; Wiig, J.N.; Giercksky, K.E.; Tretli, S. Esophageal and gastric carcinoma in Norway 1958–1992: Incidence time trend variability according to morphological subtypes and organ subsites. Int. J. Cancer 1997, 71, 340–344. [Google Scholar] [CrossRef]
- Kang, H.Y.; Kim, N.; Park, Y.S.; Hwang, J.H.; Kim, J.W.; Jeong, S.H.; Lee, D.H.; Jung, H.C.; Song, I.S. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig. Dis. Sci. 2006, 51, 2310–2315. [Google Scholar] [CrossRef] [PubMed]
- Bartley, A.N.; Rashid, A.; Fournier, K.F.; Abraham, S.C. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: Evidence for a common cell of origin in composite tumors. Hum. Pathol. 2011, 42, 1420–1429. [Google Scholar] [CrossRef] [PubMed]
- Tahara, E.; Ito, H.; Nakagami, K.; Shimamoto, F.; Yamamoto, M.; Sumii, K. Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme, and HCG. Cancer 1982, 49, 1904–1915. [Google Scholar] [CrossRef] [Green Version]
- Sato, Y.; Iwafuchi, M.; Ueki, J.; Yoshimura, A.; Mochizuki, T.; Motoyama, H.; Sugimura, K.; Honma, T.; Narisawa, R.; Ichida, T.; et al. Gastric carcinoid tumors without autoimmune gastritis in Japan: A relationship with Helicobacter pylori infection. Dig. Dis. Sci. 2002, 47, 579–585. [Google Scholar] [CrossRef] [PubMed]
- Bordi, C.; Falchetti, A.; Buffa, R.; Azzoni, C.; D’Adda, T.; Caruana, P.; Rindi, G.; Brandi, M.L. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin. Hum. Pathol. 1994, 25, 175–180. [Google Scholar] [CrossRef]
- Tanimoto, H.; Yoshida, K.; Yokozaki, H.; Yasui, W.; Nakayama, H.; Ito, H.; Ohama, K.; Tahara, E. Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol. 1991, 61, 263–267. [Google Scholar] [CrossRef] [PubMed]
- Ueki, T.; Koji, T.; Tamiya, S.; Nakane, P.K.; Tsuneyoshi, M. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. J. Pathol. 1995, 177, 353–361. [Google Scholar] [CrossRef] [PubMed]
- Hyodo, M.; Yumoto, E.; Wakisaka, H.; Mori, T.; Takada, K. Gastric scirrhous carcinoma as a rare cause of aggressive fibromatosis in the neck. Am. J. Otolaryngol. 2001, 22, 38–42. [Google Scholar] [CrossRef] [PubMed]
- Fricke, E.; Keller, G.; Becker, I.; Rosivatz, E.; Schott, C.; Plaschke, S.; Rudelius, M.; Hermannstadter, C.; Busch, R.; Hofler, H.; et al. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma. Int. J. Cancer 2003, 104, 60–65. [Google Scholar] [CrossRef] [PubMed]
- Song, S.Y.; Kim, S.; Kim, D.S.; Son, H.J.; Rhee, J.C.; Kim, Y.I. Abnormal expression of E-cadherin in early gastric carcinoma: Its relationship with macroscopic growth patterns and catenin alpha and beta. J. Clin. Gastroenterol. 2004, 38, 252–259. [Google Scholar] [CrossRef] [PubMed]
- Tamura, G.; Sakata, K.; Nishizuka, S.; Maesawa, C.; Suzuki, Y.; Iwaya, T.; Terashima, M.; Saito, K.; Satodate, R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn. J. Cancer Res. 1996, 87, 1153–1159. [Google Scholar] [CrossRef] [PubMed]
- Cho, S.Y.; Park, J.W.; Liu, Y.; Park, Y.S.; Kim, J.H.; Yang, H.; Um, H.; Ko, W.R.; Lee, B.I.; Kwon, S.Y.; et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic cdh1 alterations, but low frequency of somatic rhoa mutations compared with late-onset cancers. Gastroenterology 2017, 153, 536–549. [Google Scholar] [CrossRef] [PubMed]
- Waldum, H.L. Relationship of ECL cells and gastric neoplasia. Yale J. Biol. Med. 1998, 71, 325–335. [Google Scholar] [PubMed]
- Mjones, P.; Sagatun, L.; Nordrum, I.S.; Waldum, H.L. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation. J. Histochem. Cytochem. 2017, 65, 687–703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Intestinal Type | Diffuse Type | |
---|---|---|
Glands | Yes | No |
Age | Older | Young |
Transition from one to the other | No | No |
Macroscopic growth pattern | Tumour into the lumen | Tumour spreads along the mucosa |
Fibrosis | Not marked | Marked |
Endocrine markers | Seldom | Often |
bFGF | Seldom | Often |
E-cadherin present | Often | Seldom |
Cell of origin | Stem cell? | ECL cell? |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Waldum, H.L.; Fossmark, R. Types of Gastric Carcinomas. Int. J. Mol. Sci. 2018, 19, 4109. https://doi.org/10.3390/ijms19124109
Waldum HL, Fossmark R. Types of Gastric Carcinomas. International Journal of Molecular Sciences. 2018; 19(12):4109. https://doi.org/10.3390/ijms19124109
Chicago/Turabian StyleWaldum, Helge L., and Reidar Fossmark. 2018. "Types of Gastric Carcinomas" International Journal of Molecular Sciences 19, no. 12: 4109. https://doi.org/10.3390/ijms19124109
APA StyleWaldum, H. L., & Fossmark, R. (2018). Types of Gastric Carcinomas. International Journal of Molecular Sciences, 19(12), 4109. https://doi.org/10.3390/ijms19124109